Hims and Hers Cuts 2026 Profit Outlook
Hims and Hers lowered its full year profit forecast after higher costs for branded weight loss drugs pressured gross margins. Quarterly revenue missed estimates as the company posted a net loss.
Xurve View
Insights:
Xurve View
Hims & Hers Health Inc cut its 2026 core profit forecast to a range of $257 million to $277 million on Monday evening. The revised outlook follows margin compression driven by higher costs for branded weight-loss drugs and international expansion. Shares fell 2% in volatile after-hours trading following the announcement.
